JoAnn Lim
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
-
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Oncology 12
- Neutropenia and Cancer Infections 4
-
- Melanoma and MAPK Pathways 3
- Cancer therapeutics and mechanisms 3
- Co-authors
- Elihu H. Estey (5 shared papers)Hagop M. Kantarjian (4 shared papers)Jörge E. Cortes (3 shared papers)Issam Raad (2 shared papers)Sherry Pierce (2 shared papers)Kenneth V. I. Rolston (1 shared paper)Rhonda Fleming (1 shared paper)Rola Husni (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Investigational New Drugs (3 papers)Cancer (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Blood (2 papers)
- Partner nations
- United StatesNetherlandsBrazil
In The Last Decade
JoAnn Lim
20 papers receiving 316 citations
Peers
Comparison fields: 5 of 68
- Infectious Diseases 134
- Oncology 119
- Gastroenterology 21
- Endocrine and Autonomic Systems 22
- Epidemiology 108
Countries citing papers authored by JoAnn Lim
This map shows the geographic impact of JoAnn Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JoAnn Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JoAnn Lim more than expected).
Fields of papers citing papers by JoAnn Lim
This network shows the impact of papers produced by JoAnn Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JoAnn Lim. The network helps show where JoAnn Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside JoAnn Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 100 | |
| 2 | 2017 | 49 | |
| 3 | 2019 | 33 | |
| 4 | 2004 | 30 | |
| 5 | 2017 | 17 | |
| 6 | 2003 | 14 | |
| 7 | 2012 | 13 | |
| 8 | 2004 | 13 | |
| 9 | 2015 | 11 | |
| 10 | 2010 | 8 | |
| 11 | 2018 | 7 | |
| 12 | 2016 | 6 | |
| 13 | 2006 | 5 | |
| 14 | 2004 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2023 | 2 | |
| 18 | 2015 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2024 | 1 |
About JoAnn Lim
JoAnn Lim is a scholar working on Oncology, Molecular Biology, Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 325 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (4 papers), Neutropenia and Cancer Infections (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Melanoma and MAPK Pathways (3 papers), Cancer therapeutics and mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Fungal Infections and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Infectious Diseases (134 citations), Oncology (119 citations), Gastroenterology (21 citations), Endocrine and Autonomic Systems (22 citations) and Epidemiology (108 citations). JoAnn Lim has collaborated with scholars based in United States, Netherlands and Brazil. Frequent co-authors include Elihu H. Estey, Hagop M. Kantarjian, Jörge E. Cortes, Issam Raad, Sherry Pierce, Kenneth V. I. Rolston, Rhonda Fleming, Rola Husni, Siqing Fu and David S. Hong. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Cancer, Cancer Chemotherapy and Pharmacology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.